Connect with us

Marijuana Stocks

Barclays Pegs United States Cannabis Market Growth Would Be Near $30 Billion if Legalization Happens




Marijuana is illegal under federal law and is classified as a Schedule I substance. In a recent report, Barclays indicated that if marijuana were to be legalized across the country, governments at all levels stand to capitalize from the billions of dollars in potential revenue.

In a note to investors, Barclays analysts stated that they “estimate the total US cannabis market, if legalized, could be worth $28 billion, increasing to $1 billion by 2029 on a pre-tax basis.” If the market were to reach $41 billion, it could “generate almost $28 billion of tax revenues of government,” assuming that it were taxed at the same level as tobacco.

Analysts analyzed three states in which  adult use recreational and medical cannabis is already legal. These stages include Nevada, Washington, and Colorado, and they determined that these states are reaping a great deal from the revenues, which are already higher than that of alcohol and in Colorado, it is ahead of tobacco.

Barclays added, “While no bonds backed by cannabis tax revenues have been placed thus far, if federal approval is granted, the cannabis muni bond market will likely flourish, amounting to billions if not tens of billions of dollars, in our view.”

All information is for general informational and educational purposes only. Nothing should be interpreted as legal or wellness advice.

Jane is a regular contributor who learned about the great benefits of CBD a few years ago after starting it herself. Impressed by its effects, she's interested in helping others learn about options that can be helpful for them.

Continue Reading

Ultimate CBD Guide


ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email

Copyright © 2020 | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.